These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10685817)

  • 1. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
    Freund BJ; Schwartz M
    J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.
    Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O
    Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
    Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study.
    Freund BJ; Schwartz M
    Headache; 2000 Mar; 40(3):231-6. PubMed ID: 10759926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of whiplash associated neck pain with botulinum toxin-A: report of 8 cases.
    Freund BJ; Schwartz M
    J Rheumatol; 1999 Mar; 26(3):756-8. PubMed ID: 10090202
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
    Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
    J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin: new treatment for temporomandibular disorders.
    Freund B; Schwartz M; Symington JM
    Br J Oral Maxillofac Surg; 2000 Oct; 38(5):466-71. PubMed ID: 11010775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study.
    Wittekindt C; Liu WC; Preuss SF; Guntinas-Lichius O
    Laryngoscope; 2006 Jul; 116(7):1168-71. PubMed ID: 16826054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.